Press release
Polycystic Kidney Disease Therapeutics - Key Players Analysis Otsuka Pharmaceutical Companies (U.S.), Exelixis, XORTX Pharma Corp
PKD affects kidney along with other organs, in which development of cyst interrupts the ability to filter the waste products from blood. The disease is mostly related to high blood pressure, blood in urine, pain in back, kidney stones and heart valve abnormalities. Enlargement of cyst may lead to kidney failure which can in turn impact other organs. People with PKD are at a risk of developing aneurysm in aorta or in blood vessels in base of the brain. The disease can be categorized into two types, as autosomal dominant polycystic kidney disease (AKPKD), and autosomal recessive polycystic kidney disease (ARPKD). AKPKD generally diagnosed in adulthood, while ARPKD diagnosed in earliest months of life.
Download report sample at: https://www.psmarketresearch.com/market-analysis/polycystic-kidney-disease-therapeutics-pipeline-analysis/report-sample
*Increased Funding by the Government Organizations Contributing Immensely in Pipeline Growth
Novatarg Pharmaceuticals, received $3.2 million funding by Small Business Innovation Research (SBIR), a part of governmental agencies of National Institutes of Health, to further conduct clinical study in PKD. Novatarg Pharmaceuticals, is in the process of research and development activities of NT 1044. Through the funding, NovaTarg Pharmaceuticals had further planned to progress drug candidates for PKD and type II diabetes mellitus. In addition, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is also supporting the pharmaceutical companies to conduct clinical study and research on PKD to improve patient health.
Pre_Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=polycystic-kidney-disease-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of PKD therapeutics include Otsuka Pharmaceutical Co., Ltd., Exelixis, Inc., and XORTX Pharma Corp.
*Surge in the development of Pre-Clinical and Discovery Drug Candidates
Many pharmaceutical companies are involved in the development of therapeutic compounds by overcoming the challenges, that are effective in the treatment of PKD. They are focusing on developing the maximum drug candidates in the Pre-Clinical and Discovery stage of development. The pipeline consists of approximately eight drug candidates in the Pre-Clinical stage. GLG Pharma is in the process of developing two drug candidates in Pre-Clinical stage.
Browse report at: https://www.psmarketresearch.com/market-analysis/polycystic-kidney-disease-therapeutics-pipeline-analysis
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polycystic Kidney Disease Therapeutics - Key Players Analysis Otsuka Pharmaceutical Companies (U.S.), Exelixis, XORTX Pharma Corp here
News-ID: 1417047 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for PKD
Polycystic Kidney Disease (PKD) Market Size, Share, Trends, Demand, Future Growt …
Introduction :
Polycystic Kidney Disease (PKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys. These cysts can cause the kidneys to enlarge and lose function over time, leading to chronic kidney disease and potentially kidney failure. PKD can be categorized into two main types: Autosomal Dominant PKD (ADPKD) and Autosomal Recessive PKD (ARPKD). ADPKD is the more common form, affecting about 1 in 500 to…
Polycystic Kidney Disease (PKD) Market Analysis: Growth Trends and Forecast (202 …
Data Bridge Market Research analyses that the polycystic kidney disease (PKD) market was valued at USD 450.55 million in 2021 and is expected to reach USD 732.32 million by 2029, registering a CAGR of 6.26% during the forecast period of 2022 to 2029.
This polycystic kidney disease (PKD) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and…
Polycystic Kidney Disease (PKD) - Drug Pipeline Landscape, 2023 Updates: Analysi …
Polycystic Kidney Disease (PKD or PCKD) also known as polycystic kidney syndrome, is a genetic disorder. This causes the fluid filled cysts within the kidney. This is a form of chronic kidney disease which results in the reduction of kidney function, which may lead to kidney failure. PKD is mainly of two types: autosomal dominant PKD (ADPKD) and autosomal recessive PKD (ARPKD).
As per Global Insight services' assessment, about 20+ prominent…
Pyruvate Kinase Deficiency (PKD) Market to Evolve with Dynamic Clinical and Comm …
DelveInsight's "Pyruvate Kinase Deficiency (PKD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pyruvate Kinase Deficiency Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Pyruvate Kinase Deficiency market report covers emerging drugs, treatment practices, market share of individual therapies, and current &…
Global Polycystic Kidney Disease (PKD) Market Analysis, Scope and Forecast By 20 …
Polycystic kidney disease (PKD) is essential for a heterogeneous gathering of issues described by renal blisters and various foundational and extrarenal signs. The market forecast by Infinity Business Insights centers around the market income produced by the pharmacological treatment which are essentially indicative or palliative in nature. Antihypertensive medications to slow the weakening of Renal Function, Antibiotics to treat UTI or contaminated renal sores and Analgesics to control renal torment.
Coronavirus…
Oilfield Equipment Rental Market to 2027 - Global Analysis and Forecasts by Top …
The oil and gas industries use oilfield equipment rental services for well test and well clean-up operations. The demand for these equipment rentals is skyrocketing with the increase in global investments for exploration and production. The unconventional hydrocarbon production in the North American region is sighted as a key driver for the immense growth of the oilfield equipment rental market in this region. Additionally, the area also witnesses excessive exploration…
